Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

LM Funding America Inc.

Start price
Target price
Perf. (%)
€9.00
12.01.21
-
12.01.22
-56.44%
13.01.22

Stable Large shareholder and/or long term investor
Dependend from some customers or products
Little innovation
Probably not worthwhile Investment
buy
3D Systems Corp.

Start price
Target price
Perf. (%)
€22.77
12.01.21
€50.00
12.01.22
2.00%
09.10.21

Could be very worthwhile Investment >20% year
Tesla Inc

Start price
Target price
Perf. (%)
€228.67
11.01.21
-
11.01.22
3.06%
14.01.21

Very Future proof/growth oriented business model
Rising EBIT margin expected
Undervalued
Market Leader or Top 3
buy
Salesforce.com

Start price
Target price
Perf. (%)
€180.92
11.01.21
-
11.01.22
2.96%
25.01.21

Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
Very Future proof/growth oriented business model
buy
Mastercard Inc. A

Start price
Target price
Perf. (%)
€289.25
11.01.21
€340.00
11.01.22
11.93%
12.01.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
3D Systems Corp.

Start price
Target price
Perf. (%)
€20.00
11.01.21
€50.00
11.01.22
13.83%
12.01.21

Could be very worthwhile Investment >20% year
buy
Stratasys Inc.

Start price
Target price
Perf. (%)
€24.14
11.01.21
€50.00
11.01.22
-5.59%
09.10.21

Could be very worthwhile Investment >20% year
buy
PolarityTE Inc.

Start price
Target price
Perf. (%)
€32.25
11.01.21
-
11.01.22
-41.09%
27.01.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
buy
Asensus Surgical Inc.

Start price
Target price
Perf. (%)
€1.72
11.01.21
-
11.01.22
40.70%
19.01.21

Capable Management
Good culture
Dependend from some customers or products
buy
LM Funding America Inc.

Start price
Target price
Perf. (%)
€15.10
11.01.21
-
11.01.22
-73.38%
12.01.22

Could be worthwhile Investment >10% per year
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.60
11.01.21
€6.00
11.01.22
10.87%
25.01.21

Could be worthwhile Investment >10% per year
buy
Lumos Pharma Inc.

Start price
Target price
Perf. (%)
€18.00
11.01.21
€25.00
11.01.22
-17.22%
25.01.21

Could be worthwhile Investment >10% per year
buy
Evolus Inc

Start price
Target price
Perf. (%)
€3.62
11.01.21
€4.00
77.53%
25.01.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.40
11.01.21
€8.00
17.97%
25.01.21

Could be very worthwhile Investment >20% year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.79
11.01.21
€2.00
11.01.22
166.14%
25.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€87.00
11.01.21
€99.00
11.01.22
23.33%
27.07.21

Could be worthwhile Investment >10% per year
Good culture
Future proof or reliable business model
Market Leader or Top 3
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€42.23
11.01.21
€60.00
11.01.22
-38.47%
04.01.22

Small cyclical dependencies
Known brand
Capable Management
Top 10 in its market
Uranium Energy Corp

Start price
Target price
Perf. (%)
€1.68
11.01.21
-
11.01.22
-12.47%
22.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Leggett & Platt Inc.

Start price
Target price
Perf. (%)
€35.80
11.01.21
-
11.01.22
11.12%
18.10.21

EBIT growth >5% per year expected
High dividend yield expected
Revenue growth >5% per year expected
buy
FutureFuel Corp.

Start price
Target price
Perf. (%)
€11.10
10.01.21
€20.00
10.01.22
-33.78%
11.01.22

Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Federal Realty Investment Trust

Start price
Target price
Perf. (%)
€69.53
10.01.21
-
10.01.22
29.50%
20.04.21

Very high dividend yield expected
High valuation
Revenue decline/stagnation expected
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€21.74
10.01.21
-
10.01.22
39.88%
23.01.21

Risky Investment
buy
StoneMor Inc.

Start price
Target price
Perf. (%)
€2.22
10.01.21
-
10.01.22
20.72%
23.01.21

Risky Investment
buy
Cal-Maine Foods Inc.

Start price
Target price
Perf. (%)
€30.80
10.01.21
-
10.01.22
14.94%
11.01.22

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Strong uniques